Fig. 10From: Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancersSchematic diagram showing the synergistic effect between Mn2+ and YM101. On the one hand, Mn2+ promoted dendritic cell (DC) maturation. On the other hand, YM101 restrained cancer-associated fibroblast (CAF) activity, enhanced T cell infiltration and restored T cell from exhaustion. The effects of Mn2+ and YM101 were independent and complementary, and the combination therapy had a potent and broad-spectrum antitumor effectBack to article page